Agena Bioscience
Dedicated to advancing the impact of genomics in healthcare and precision medicine.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
$300m Valuation: $300m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Agena Bioscience, part of Mesa Clinical Genomics Division, is a global provider of genetic testing solutions headquartered in San Diego. The company specializes in delivering scalable and affordable targeted genomic data to research laboratories. Agena Bioscience operates in the molecular genomics market, serving healthcare and laboratory sciences sectors. The business model revolves around the development and distribution of advanced genetic testing platforms, such as the MassARRAY Dx, which are primarily for research use. Revenue is generated through the sale of these platforms and associated services. Agena Bioscience maintains high-quality standards, evidenced by its ISO accreditation, and collaborates with institutions like Manchester University to expand educational resources in pharmacogenomics. The company fosters innovation and diversity within its global team, emphasizing career development and scientific leadership.
Keywords: genetic testing, targeted genomics, molecular genomics, research laboratories, pharmacogenomics, MassARRAY Dx, healthcare, laboratory sciences, ISO accreditation, educational resources.